An ambitious data-center project in Utah is going to need about one-quarter of the power the entire state currently uses. David Gray, co-chief executive for the project’s developer, knows he can’t get ...

Discover how to build a simple solar cell at home using everyday materials! This step-by-step tutorial demonstrates how to repurpose an aluminum can, a CD, copper wire, toothpaste, lemon juice, and a ...

Getting a good night’s sleep could slash the risk of developing psoriasis by nearly a third. Research shows adults who sleep seven to eight hours a night are much less likely than insomniacs to get ...

The Science Advances publication details Cellgorithm™, a CRISPR-based technology that gives researchers greater control over gene activity and sets the stage for future applications in stem cell ...

Galapagos (NASDAQ:GLPG) ADRs dropped ~13% in the premarket on Tuesday after the Belgian biotech announced plans to wind down its cell therapy business, impacting roughly 365 employees in Europe, the U ...

Galapagos is planning to wind down its cell therapy business, completing a whiplash change that saw the biotech go from focusing on the modality to ditching it in six months. Belgium-based Galapagos ...

View post: Amazon’s 'Well-Built' 10-Piece Wrench Set Is Now 43% Off, and It Can ‘Fit Into Tight Spots’ Nearly half of American homeowners admit to being afraid of dealing with all the clutter in their ...

We thought we were buying a storage unit full of forgotten junk. Turns out, it was one of the most profitable finds we’ve ever made. Among the dust and cobwebs sat a rare item that made the entire ...

Oct 10 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab has decided to discontinue its cell therapy research and development efforts, a spokesperson for the Danish drugmaker told Reuters on Friday.

Ozempic maker Novo Nordisk (NVO) is closing its cell therapy division as part of a major restructuring drive initiated under the company’s new CEO, Mike Doustdar, Bloomberg News reported on Thursday, ...

A simple AI model has been shown to perform on a par with experienced dermatologists when assessing the aggressiveness of a common form of skin cancer, squamous cell carcinoma. The research was headed ...